Dexamethasone Sodium Phosphate
Dexamethasone Sodium Phosphate Injection, USP Rx only
Approved
Approval ID
69344707-904d-7ba2-e053-2a91aa0a31f4
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 23, 2023
Manufacturers
FDA
Medical Purchasing Solutions, LLC
DUNS: 601458529
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Dexamethasone Sodium Phosphate
PRODUCT DETAILS
NDC Product Code71872-7091
Application NumberANDA087702
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMay 23, 2023
Generic NameDexamethasone Sodium Phosphate
INGREDIENTS (7)
SODIUM CITRATEInactive
Quantity: 16.5 mg in 1 mL
Code: 1Q73Q2JULR
Classification: IACT
SODIUM SULFITEInactive
Quantity: 1.5 mg in 1 mL
Code: VTK01UQK3G
Classification: IACT
BENZYL ALCOHOLInactive
Quantity: 10.42 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
DEXAMETHASONE SODIUM PHOSPHATEActive
Quantity: 10 mg in 1 mL
Code: AI9376Y64P
Classification: ACTIR